|
|
Suppliers for
Betahistine
|
Properties | CAS |
5638-76-6 | Formula |
C8H12N2 | EINECS |
227-086-4 |
|
|
5 Registered suppliers
Description : Betahistine is a H1 receptor agonist, which serves as a vasodilator. It is used in Meniere disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. It is believed to act by reducing the asymmetrical functioning of sensory vestibular organs as well as by increasing vestibulocochlear blood flow. It also acts as a histamine H3-receptor antagonist which causes an increased output of histamine from histaminergic nerve endings which can further increase the direct H1-agonist activity. It has been listed. - Molecular Weight :136.19
- Boiling Point :113-114 ℃
- Melting Point :148-149 ℃
- Purity :98 %
Molecular Formula : C8H12N2 Canonical SMILES : CNCCC1=CC=CC=N1 InChI : InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3 InChIKey : UUQMNUMQCIQDMZ-UHFFFAOYSA-N Solubility : Soluble in DMSO, not in water Appearance : Colourless liquid Application : Betahistine is used in Meniere disease and in vascular headaches. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. Storage : -20 ℃ Freezer Synonyms : N-methyl-2-pyridin-2-ylethanamine
More details are to be found here
Description : Betahistine is a H1 receptor agonist, which serves as a vasodilator. It is used in Meniere disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. It is believed to act by reducing the asymmetrical functioning of sensory vestibular organs as well as by increasing vestibulocochlear blood flow. It also acts as a histamine H3-receptor antagonist which causes an increased output of histamine from histaminergic nerve endings which can further increase the direct H1-agonist activity. It has been listed. - Molecular Weight :136.19
- Boiling Point :113-114 ℃
- Melting Point :148-149 ℃
- Purity :98 %
Molecular Formula : C8H12N2 Canonical SMILES : CNCCC1=CC=CC=N1 InChI : InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3 InChIKey : UUQMNUMQCIQDMZ-UHFFFAOYSA-N Solubility : Soluble in DMSO, not in water Appearance : Colourless liquid Application : Betahistine is used in Meniere disease and in vascular headaches. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. Storage : -20 ℃ Freezer Synonyms : N-methyl-2-pyridin-2-ylethanamine
More details are to be found here
Description : Betahistine is a H1 receptor agonist, which serves as a vasodilator. It is used in Meniere disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. It is believed to act by reducing the asymmetrical functioning of sensory vestibular organs as well as by increasing vestibulocochlear blood flow. It also acts as a histamine H3-receptor antagonist which causes an increased output of histamine from histaminergic nerve endings which can further increase the direct H1-agonist activity. It has been listed. - Molecular Weight :136.19
- Boiling Point :113-114 ℃
- Melting Point :148-149 ℃
- Purity :98 %
Molecular Formula : C8H12N2 Canonical SMILES : CNCCC1=CC=CC=N1 InChI : InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3 InChIKey : UUQMNUMQCIQDMZ-UHFFFAOYSA-N Solubility : Soluble in DMSO, not in water Appearance : Colourless liquid Application : Betahistine is used in Meniere disease and in vascular headaches. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. Storage : -20 ℃ Freezer Synonyms : N-methyl-2-pyridin-2-ylethanamine
More details are to be found here
|
Properties:
... more properties and specification on Betahistine
|
|
Privileged suppliers
Last update 2024-06-03
|